United States: FDA's Decentralized Trial Guidance: Investigator, Health Care Provider Demarcation Raises Questions - Morrison & Foerster LLP

Credit: Mondaq- Published on July 28, 2023
And if a subject is interacting with the health care system outside of the trials, what is the best way of capturing that data?"

You are here


Related videos from verified sources

Johnson & Johnson Joins Fight Against Lowering Drug Prices in the US 01:30
Credit: Wibbitz Top Stories - Published on July 19, 2023 


You might like